SpanishSpanish    SMSSend SMS
Yashica Pharmaceuticals
Yashica Pharmaceuticals
Yashica Pharmaceuticals

Yashica Pharmaceuticals

Yashica

Yashica PharmaceuticalsYashica Pharmaceuticals

Home » Finished Formulation » Cetirizine Tablets

Cetirizine Tablets

«  Back | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next  »

NAME OF PRODUCT : YASHICET (Cetirizine Tablets BP 10 mg)
TEST SPECIFICATION AS PER USP
1) Description A white coloured, oblong shaped, biconvex film coated tablet bisected on one side and plain on other side.
2) Identification by IR Should comply as per BP
3) Uniformity of weight within ± 7.5% of average weight
4) Average Weight 131.00 mg ± 7.5%
5) Thickness 2.90 mm ± 0.2 mm
6) Diameter 10.30 mm ± 0.2 mm
5) Uniformity of Content 85.0% to 115.0%
6) Disintegration Time NMT 30 min in water medium at 37?
7) Dissolution NLT 80.0% (Q) of LA
8) Related Substances Should comply as per BP
9) Assay of Cetirizine Hydrochloride 95.0% to 105.0% of Label claim
(9.50 mg to 10.50 mg)

Yes! I am Interested

Chloroquine Tabs

NAME OF PRODUCT : YASHIQUIN (Chloroquine Tablets BP 150 mg)
TEST SPECIFICATION AS PER USP
1) Description A white coloured, round shaped, biconvex film coated tablet plain on both side.
2) Identification by IR Should comply as per BP
3) Uniformity of weight within ± 5% of average weight
4) Average Weight 185.00 mg ± 3%
5) Thickness 3.40 mm ± 0.2 mm
6) Diameter 8.10 mm ± 0.2 mm
7) Disintegration Time NMT 30 min
8) Dissolution NLT 70.0% (Q) of LA
9) Related Substances Should comply as per BP
10) Assay of Chloroquine Phosphate 92.5% to 107.5% of Label claim

Yes! I am Interested

Chlorpromazine Injection

NAME OF PRODUCT : YASHICLOZINE INJECTION 2 ML (CHLORPROMAZINE INJECTION BP 5MG/ML)
TEST SPECIFICATION AS PER USP
Description A clear colourless solution
Identification Should comply as pr BP
Volume Variation NLT 2.0 mL
pH 5.0 to 6.5
Particulate Matter Sample should be free from particles
Sterility Should comply as per BP
Related Substances Should comply as per BP
Assay - Each mL contains:
Chlorpromazine HCl BP - 25mg
95.0% to 105.0%




Yes! I am Interested

Ciprofloxacin Tablets

NAME OF PRODUCT : Ciprofloxacin Tablets
TEST SPECIFICATION AS PER USP
TEST SPECIFICATION
Description A white coloured, oblong shaped, biconvex film coated tablet with break-line on one side.
Identification (HPLC): Should comply as per USP
The principal peak obtained in the chromatogram of test solution should correspond to the peak obtained in the chromatogram of reference solution.
Average Weight of 20 Tablets 755.00 mg ± 5%
Uniformity of weight Within ± 5% of average weight
Height 16.60 mm ± 0.1 mm
Thickness 5.80 mm ± 0.2 mm
Disintegration Time NMT 30 min in water at 37?
Dissolution NLT 80% (Q)
Assay: Each Film coated tablet contains:
Ciprofloxacin Hydrochloride USP eq. to Ciprofloxacin 500mg

90.0% to 110.0%
450 mg to 550 mg

Yes! I am Interested

Clarithromycin Syrup

NAME OF PRODUCT : Clarithromycin Syrup
TEST SPECIFICATION AS PER USP
Test In-House Specification
Description A white to light pink coloured strawberry flavored granular powder.
Identification Must complies as per USP
The retention time of the major peak of the sample solution corresponds to that of the standard solution as obtained in the assay.
pH 4.0 – 5.4
Net filled Volume 10.0 gm/60 mL
Wt. per ml About 1 gm/ml
Loss on Drying NMT 2.0 %
Assay Each 5 ml of reconstituted suspension contains
Clarithromycin USP……..125 mg
LIMIT: 90.0 % to 115.0%
After 7 days
Clarithromycin USP……125 mg
LIMIT: 90.0 % to 115.0%

Yes! I am Interested

Dexamathasone Injection

NAME OF PRODUCT : YASHIDEX INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP 4MG/ML)
TEST SPECIFICATION AS PER USP
TEST SPECIFICATION AS PER USP
Description A clear colourless solution
Identification Should comply as pr USP
Volume Variation NLT 1.0 mL
pH 7.0 to 8.5
Color and Clarity Should be clear and colorless
Particulate Matter Sample should be free from particulate matter
Sterility Should be sterile
Assay - Each mL contains: Dexamethasone Sodium Phosphate USP eq. to Dexamethasone Phosphate - 4mg 90.0% to 115.0%

Yes! I am Interested

Dimercaprol Injection

NAME OF PRODUCT : YASHICAPROL (DIMERCAPROL INJECTION USP 100MG/2ML)
TEST SPECIFICATION AS PER USP
Description A slightly yellow colored viscous solution
Identification Should comply as pr USP
Average Volume of 10 containers NLT 2.0 mL
Nominal Volume 2.0 ml
Color and Clarity Should be slightly yellow colored viscous solution
Assay - Each mL contains: 90.0% to 110.0%
Dimercaprol USP – 50 mg  






Yes! I am Interested

Frusemide Injection

NAME OF PRODUCT : YASHIFRU INJECTION 2 ML (FUROSEMIDE INJECTION USP 20MG/2ML)
TEST SPECIFICATION AS PER USP
Description A clear colourless solution
Identification Should comply as pr USP
Volume Variation NLT 2.0 mL
pH 8.0 to 9.3
Particulate Matter Sample should meet the requirements of small volume injections
Sterility Should comply as per USP
Assay - Each mL contains: Furosemide USP (as Sodium) - 10mg 90.0% to 110.0%
  (9.00 mg - 11.00 mg)

Yes! I am Interested

«  Back | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next  »

Our Product Range :     Active Pharmaceuticals Ingredients |Drug Intermediates | Finished Formulation

Home|About Us|Our Product Range|Media Gallery|Contact Us|Enquiry

Member INDIAMART© Yashica Pharmaceuticals Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Looking for Product Name ?

x

Send SMS Enquiry

*Please Enter Requirment

*Please Enter valid Mobile Number

*Please Enter Proper Name